HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rafael Villasmil Selected Research

Leukemia

1/2018STAT-3-independent production of IL-17 by mouse innate-like αβ T cells controls ocular infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rafael Villasmil Research Topics

Disease

4Macular Degeneration (Age-Related Maculopathy)
11/2022 - 10/2013
3Neoplasms (Cancer)
01/2024 - 01/2019
2Infections
07/2023 - 04/2002
2Uveitis
04/2015 - 08/2013
1Thrombosis (Thrombus)
01/2024
1Hemorrhage
01/2024
1Thromboinflammation
01/2024
1Sickle Cell Anemia (Hemoglobin S Disease)
01/2024
1Atrophy
11/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Choroidal Neovascularization
01/2019
1Retinal Degeneration
01/2019
1Retinal Diseases
01/2019
1Neuroinflammatory Diseases
01/2019
1Inflammation (Inflammations)
01/2018
1Staphylococcal Infections
01/2018
1Eye Infections
01/2018
1Leukemia
01/2018
1Anterior segment mesenchymal dysgenesis
01/2016
1Optic Nerve Diseases (Optic Neuropathy)
02/2014
1Optic Nerve Injuries
02/2014
1Glaucoma
02/2014
1Disease Progression
09/2002
1Anthrax
04/2002

Drug/Important Bio-Agent (IBA)

3Retinaldehyde (Retinal)IBA
01/2019 - 02/2014
2Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2019
2Proteins (Proteins, Gene)FDA Link
07/2023 - 01/2019
2LipidsIBA
07/2023 - 11/2022
2interstitial retinol-binding proteinIBA
04/2015 - 08/2013
2Virulence Factors (Pathogenicity Factors)IBA
09/2002 - 04/2002
1LigandsIBA
01/2024
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2024
1AlbuminsIBA
01/2024
1isoquercitrinIBA
01/2024
1AntigensIBA
11/2023
1Immune Checkpoint InhibitorsIBA
11/2023
1AntibodiesIBA
07/2023
1GW 3965IBA
07/2023
1OxysterolsIBA
07/2023
1Angiotensin-Converting Enzyme 2IBA
07/2023
125-hydroxycholesterolIBA
07/2023
1CholesterolIBA
07/2023
1CyclodextrinsIBA
07/2023
1Dihydrotachysterol (AT 10)IBA
07/2023
1Indomethacin (Indometacin)FDA LinkGeneric
07/2023
1Lovastatin (Mevacor)FDA LinkGeneric
07/2023
1Nystatin (Mycostatin)FDA LinkGeneric
07/2023
1VimentinIBA
07/2023
1Dynamins (Dynamin)IBA
07/2023
1Dynamin IIBA
07/2023
1Small Interfering RNA (siRNA)IBA
07/2023
1syncytinIBA
01/2019
1Annexin A5IBA
01/2019
1CytokinesIBA
01/2019
1InterleukinsIBA
01/2019
1A-factor (Streptomyces)IBA
01/2019
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2018
1Interleukin-17 (Interleukin 17)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2016
1Neuroprotective AgentsIBA
02/2014
1Complement System Proteins (Complement)IBA
10/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2013
1ubenimexIBA
04/2002

Therapy/Procedure

3Therapeutics
11/2023 - 02/2014
1Radiotherapy
11/2023
1Drug Therapy (Chemotherapy)
11/2023
1Lasers (Laser)
01/2019
1Ligation
01/2018
1Transplantation
02/2014